deoxyglucose has been researched along with lovastatin in 3 studies
| Studies (deoxyglucose) | Trials (deoxyglucose) | Recent Studies (post-2010) (deoxyglucose) | Studies (lovastatin) | Trials (lovastatin) | Recent Studies (post-2010) (lovastatin) |
|---|---|---|---|---|---|
| 11,426 | 171 | 1,375 | 4,828 | 698 | 873 |
| Protein | Taxonomy | deoxyglucose (IC50) | lovastatin (IC50) |
|---|---|---|---|
| Chain A, Antigen Cd11a (p180) | Homo sapiens (human) | 2.4 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0261 | |
| Integrin beta-2 | Homo sapiens (human) | 3.09 | |
| Intercellular adhesion molecule 1 | Homo sapiens (human) | 3.78 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.753 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 10 | |
| Neutrophil elastase | Homo sapiens (human) | 0.027 | |
| Insulin receptor | Rattus norvegicus (Norway rat) | 0.02 | |
| Integrin alpha-L | Homo sapiens (human) | 3.09 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.753 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.02 | |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0529 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Hanson, SY; Johnson, AC; Zager, RA | 1 |
| Chen, JH; Du, JJ; Huang, JJ; Huang, XM; Huang, Z; Lin, QY; Lin, WJ; Long, Z; Ma, WZ; Qin, X; Shen, YF; Yang, Y; Zhang, N; Zheng, BW; Zhong, FF | 1 |
| Asperti, M; Bernardi, S; Cassandri, M; Codenotti, S; Fanzani, A; Gastaldello, S; Giacomini, A; Mandracchia, D; Marampon, F; Mignani, L; Mitola, S; Monti, E; Parolini, S; Poli, M; Rezzola, S; Rota, R; Russo, D; Tabellini, G; Tomasini, D; Triggiani, L; Vezzoli, M; Zizioli, D | 1 |
3 other study(ies) available for deoxyglucose and lovastatin
| Article | Year |
|---|---|
Proximal tubular cholesterol loading after mitochondrial, but not glycolytic, blockade.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Anticholesteremic Agents; Antimetabolites; Antimycin A; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; CD36 Antigens; Cell Line, Transformed; Cholesterol; Deoxyglucose; Glycolysis; Humans; Hydroxymethylglutaryl CoA Reductases; Kidney Tubules, Proximal; Lovastatin; Membrane Proteins; Mitochondria; Protein Prenylation; ras Proteins; Receptors, Immunologic; Receptors, LDL; Receptors, Lipoprotein; Receptors, Scavenger; rho GTP-Binding Proteins; Rotenone; Scavenger Receptors, Class B; Uncoupling Agents | 2003 |
Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.
Topics: Animals; Antimetabolites; Autophagy; Cell Survival; Chloroquine; Colorectal Neoplasms; Deoxyglucose; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; HCT116 Cells; HEK293 Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; Proto-Oncogene Proteins p21(ras); Xenograft Model Antitumor Assays | 2021 |
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors.
Topics: Animals; Child; Deoxyglucose; DNA Repair; DNA-Activated Protein Kinase; Doxorubicin; Glucose; Glycolysis; Hexokinase; Histones; Humans; Ki-67 Antigen; Lovastatin; Mevalonic Acid; MTOR Inhibitors; Oxidoreductases; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Proto-Oncogene Proteins c-akt; Rhabdomyosarcoma, Embryonal; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; TOR Serine-Threonine Kinases; Zebrafish | 2022 |